UNSW medical researchers have developed a new way to predict whether patients with the blood condition myelodysplastic syndrome will respond to treatment.
We have developed a stem cell technique capable of regenerating any human tissue damaged by injury, disease or ageing, write John Pimanda, Ralph Mobbs and Vashe Chandrakanthan.
